Table 2 Associations between LncRNA MALAT1 rs3200401 genotypes and survival of early-staged NSCLC patients
Genotypes | Patients (%) | Deaths | MST (months) | Log-rank P | Crude HR (95% CI) | Crude P | Adjusted HR (95% CI)a | Adjusted P |
|---|---|---|---|---|---|---|---|---|
All patients | ||||||||
 CC | 86 | 48 | 55.3 | -- | 1.00 (Reference) | --- | 1.00 (Reference) | --- |
 CT | 49 | 26 | 61.4 | 0.940 | 0.92 (0.57–1.48) | 0.717 | 0.92 (0.56–1.51) | 0.734 |
 TT | 3 | 2 | 39.2 | 0.980 | 1.15 (0.28–4.77) | 0.848 | 1.07 (0.25–4.65) | 0.929 |
 CT + TT | 52 | 28 | 61.4 | 0.760 | 0.93 (0.58–1.48) | 0.756 | 0.93 (0.57–1.51) | 0.760 |
Adenocarcinoma | ||||||||
 CC | 37 | 18 | 62.9 | -- | 1.00 (Reference) | --- | 1.00 (Reference) | --- |
 CT | 18 | 6 | --- | 0.650 | 0.65 (0.25–1.64) | 0.357 | 0.42 (0.15–1.19) | 0.104 |
 TT | 1 | 0 | --- | --- | --- | --- | --- | --- |
 CT + TT | 19 | 6 | --- | 0.290 | 0.61 (0.24–1.55) | 0.297 | 0.40 (0.14–1.12) | 0.082 |
Squamous cell carcinoma | ||||||||
 CC | 41 | 25 | 48.6 | -- | 1.00 (Reference) | --- | 1.00 (Reference) | --- |
 CT | 26 | 16 | 57.6 | 0.920 | 0.88 (0.46–1.65) | 0.683 | 0.81 (0.40–1.64) | 0.563 |
 TT | 1 | 1 | 41.2 | 0.880 | 1.63 (0.22–12.23) | 0.635 | 1.58 (0.17–14.49) | 0.685 |
 CT + TT | 27 | 17 | 57.6 | 0.740 | 0.90 (0.48–1.68) | 0.743 | 0.83 (0.42–1.66) | 0.602 |